Akero Therapeutics, Inc.

AKRODelisted Dec 9, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001744659

SEC filings (opens in a new tab)

Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Akero Therapeutics, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of AKRO: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Of which not filed for Q3 2023	Q3 2023	Change
Holders	157	2	181	+26
Shares	56.4M	1.21M	57.1M	+1.95M (+3.5%)
Value	$2.63B	$56.3M	$2.90B	+$326.9M (+12.7%)

2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (38)

Institutions that held Akero Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to AKRO in Q3 2023
Institution	Shares	Value	% of portfolio
Avoro Capital Advisors LLC	555,555	$28.1M	0.44%
Pictet Asset Management Holding SA	399,285	$20.2M	0.02%
PFM Health Sciences, LP	214,298	$10.8M	0.52%
Ikarian Capital, LLC	200,000	$10.1M	3.76%
Great Point Partners LLC	198,500	$10.0M	1.89%
University of Wisconsin Foundation	103,816	$5.25M	6.02%
Bridger Management, LLC	101,500	$5.13M	1.88%
Peregrine Capital Management LLC	95,447	$4.83M	0.14%
Clough Capital Partners L P	72,200	$3.65M	0.39%
Twinbeech Capital LP	54,780	$2.77M	0.05%
Boothbay Fund Management, LLC	40,280	$2.04M	0.07%
Point72 Asset Management, L.P.	38,600	$1.95M	0.01%
Squarepoint Ops LLC	35,591	$1.80M	0.01%
Tudor Investment Corp Et Al	31,881	$1.61M	0.02%
Cubist Systematic Strategies, LLC	24,246	$1.23M	0.02%
Macquarie Group Ltd	22,785	$1.15M	0.00%
Holocene Advisors, LP	21,873	$1.11M	0.00%
Gsa Capital Partners LLP	20,597	$1.04M	0.09%
Atom Investors LP	19,080	$965.1K	0.22%
GTS Securities LLC	15,986	$808.6K	0.02%
Healthcare of Ontario Pension Plan Trust Fund	12,000	$607.0K	0.00%
HighVista Strategies LLC	11,408	$577.0K	0.27%
Prelude Capital Management, LLC	11,243	$568.7K	0.05%
Envestnet Asset Management Inc	9,426	$476.8K	0.00%
XTX Topco Ltd	8,122	$410.8K	0.07%
Dynamic Technology Lab Private Ltd	8,060	$408.0K	0.04%
AlphaCentric Advisors LLC	8,000	$404.6K	0.23%
Bayesian Capital Management, LP	5,634	$285.0K	0.03%
Wolverine Trading, LLC	4,871	$246.4K	0.00%
Miracle Mile Advisors, LLC	4,700	$237.7K	0.01%
Farallon Capital Management, L.L.C.	4,000	$202.3K	0.00%
KBC Group NV	1,521	$77.0K	0.00%
Quarry LP	1,250	$63.2K	0.04%
Orion Capital Management LLC	1,000	$50.6K	0.03%
Comerica Bank	236	$11.9K	0.00%
Cullen/Frost Bankers, Inc.	150	$7.59K	0.00%
Private Trust Co NA	61	$3.08K	0.00%
Bell Investment Advisors, Inc	11	$557	0.00%

Sold out (12)

Institutions that held Akero Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of AKRO in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Skorpios Trust	1,621,829	$75.7M
Pier Capital, LLC	147,841	$6.90M
Norges Bank	136,377	$6.37M
Cormorant Asset Management, LP	115,000	$5.37M
Walleye Capital LLC	59,677	$2.79M
EAM Investors, LLC	50,856	$2.37M
Lazard Asset Management LLC	6,349	$296.0K
Millennium Management LLC	4,884	$228.0K
Federated Hermes, Inc.	3,584	$167.3K
Belvedere Trading LLC	1,758	$82.1K
First Manhattan Co	150	$7.00K
Impact Partnership Wealth, LLC	28	$1.31K

Not filed for Q3 2023 yet (2)

Institutions that held Akero Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AKRO in Q2 2023 that haven't filed for Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Pictet Asset Management SA	1,144,082	$53.4M
Tekla Capital Management LLC	61,497	$2.87M